MA | ||
---|---|---|
OUTLOOK RATING 1..100 | 83 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 13 | |
SMR RATING 1..100 | 11 | |
PRICE GROWTH RATING 1..100 | 32 | |
P/E GROWTH RATING 1..100 | 38 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACWV | MA | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 1 day ago67% | 1 day ago51% |
Momentum ODDS (%) | 1 day ago74% | 1 day ago64% |
MACD ODDS (%) | 1 day ago78% | 1 day ago51% |
TrendWeek ODDS (%) | 1 day ago78% | 1 day ago56% |
TrendMonth ODDS (%) | 1 day ago74% | 1 day ago54% |
Advances ODDS (%) | 3 days ago76% | 2 days ago51% |
Declines ODDS (%) | 16 days ago68% | 17 days ago53% |
BollingerBands ODDS (%) | 1 day ago71% | 1 day ago44% |
Aroon ODDS (%) | 1 day ago59% | 1 day ago52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SMLV | 128.01 | 2.88 | +2.30% |
SPDR® SSGA US Small Cap Low Volatil ETF | |||
CVRD | 18.54 | N/A | N/A |
Madison Covered Call ETF | |||
LFAX | 163.88 | N/A | N/A |
LifeX 2061 Longevity Income ETF | |||
JEPQ | 55.80 | -0.01 | -0.02% |
JPMorgan Nasdaq Equity Premium Inc ETF | |||
RA | 13.13 | -0.02 | -0.15% |
Brookfield Real Assets Income Fund |
A.I.dvisor indicates that over the last year, ACWV has been closely correlated with LIN. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACWV jumps, then LIN could also see price increases.
Ticker / NAME | Correlation To ACWV | 1D Price Change % | ||
---|---|---|---|---|
ACWV | 100% | +0.30% | ||
LIN - ACWV | 75% Closely correlated | +0.51% | ||
L - ACWV | 73% Closely correlated | -0.61% | ||
ROP - ACWV | 68% Closely correlated | +0.89% | ||
MMC - ACWV | 67% Closely correlated | +0.11% | ||
MA - ACWV | 66% Closely correlated | -0.35% | ||
More |